News & Updates

Urea on par with tolvaptan for hyponatremia
Urea on par with tolvaptan for hyponatremia
30 Nov 2024
Weight loss interventions ease symptoms, improve biomarkers of PCOS
Weight loss interventions ease symptoms, improve biomarkers of PCOS
29 Nov 2024
Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
28 Nov 2024

Individuals with worsening chronic kidney disease (CKD) are at greater risk for emergently treated hypocalcemia with denosumab, and the highest risk is observed among dialysis-dependent (DD) patients and those with CKD–mineral and bone disorder (CKD-MBD), reveals a study.

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
28 Nov 2024